Fabry's disease epidemiology and demographics

Fabry's disease Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Fabry's disease from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Fabry's disease epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Fabry's disease epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Fabry's disease epidemiology and demographics
CDC on Fabry's disease epidemiology and demographics
Fabry's disease epidemiology and demographics in the news
Blogs on Fabry's disease epidemiology and demographics
Directions to Hospitals Treating Fabry's disease
Risk calculators and risk factors for Fabry's disease epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Epidemiology and Demographics

FD belong to a group of lysosomal storage diseases that are related biochemically but not genetically. The , the classical type is severe and presents relatively early in childhood.

variant type is milder and occurs in adolescence or adulthood

Prevalence

The prevalence of Fabry disease is estimated to range from 1:17,000 to 1:117,000 males in Caucasian populations.